Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
79,000 results
  • Oral semaglutide for type 2 diabetes: a systematic review and meta-analysis. [Journal Article]
    Diabetes Obes Metab 2019Avgerinos I, Michailidis T, … Bekiari E
  • CONCLUSIONS: Oral semaglutide can effectively and safely reduce blood glucose, body weight and systolic blood pressure. Nevertheless, it is associated with increased incidence of gastrointestinal adverse events. Further research is needed to clarify its long-term safety and comparative effectiveness against other antidiabetic agents. This article is protected by copyright. All rights reserved.
  • Radiomics Nomogram Analyses for Differentiating Pneumonia and Acute Paraquat Lung Injury. [Journal Article]
    Sci Rep 2019; 9(1):15029Yanling W, Duo G, … Hongying C
  • Paraquat poisoning has become a serious public health problem in some Asian countries because of misuse or suicide. We sought to develop and validate a radiomics nomogram incorporating radiomics signature and laboratory bio-markers, for differentiating bacterial pneumonia and acute paraquat lung injury. 180 patients with pneumonia and acute paraquat who underwent CT examinations between December …
  • Olanzapine as a rescue antiemetic in hematopoietic stem cell transplant. [Journal Article]
    J Oncol Pharm Pract 2019; :1078155219879215Monson T, Greer D, … Liewer S
  • CONCLUSIONS: Olanzapine was associated with significant improvements in breakthrough nausea and vomiting control while reducing the number of emesis episodes and required antiemetic doses in the hematopoietic stem cell transplant population. Olanzapine may be beneficial in optimizing antiemetic regimens for breakthrough chemotherapy-induced nausea and vomiting control in patients undergoing hematopoietic stem cell transplant.
New Search Next